Hemispherx Biopharma

Results: 9



#Item
1FDA Public Workshop Development of Safe and Effective Drug Therapies for CFS and ME Speaker, Panelist and Moderator Disclosure Form April 25 and 26, 2013 Dear Speaker, Panelist or Moderator: Please complete this form reg

FDA Public Workshop Development of Safe and Effective Drug Therapies for CFS and ME Speaker, Panelist and Moderator Disclosure Form April 25 and 26, 2013 Dear Speaker, Panelist or Moderator: Please complete this form reg

Add to Reading List

Source URL: www.fda.gov

Language: English
2Microsoft Word - Summary Minutes AAC[removed]12_clean.doc

Microsoft Word - Summary Minutes AAC[removed]12_clean.doc

Add to Reading List

Source URL: www.fda.gov

Language: English
3FOOD AND DRUG ADMINISTRATION Center for Drug Evaluation and Research Arthritis Advisory Committee (AAC) Meeting FDA White Oak Campus, Building 31, The Great Room (Rm[removed]White Oak Conference Center, Silver Spring, Mar

FOOD AND DRUG ADMINISTRATION Center for Drug Evaluation and Research Arthritis Advisory Committee (AAC) Meeting FDA White Oak Campus, Building 31, The Great Room (Rm[removed]White Oak Conference Center, Silver Spring, Mar

Add to Reading List

Source URL: www.fda.gov

Language: English
4FOOD AND DRUG ADMINISTRATION Center for Drug Evaluation and Research Arthritis Advisory Committee (AAC) Meeting FDA White Oak Campus, Building 31, The Great Room (Rm[removed]White Oak Conference Center, Silver Spring, Mar

FOOD AND DRUG ADMINISTRATION Center for Drug Evaluation and Research Arthritis Advisory Committee (AAC) Meeting FDA White Oak Campus, Building 31, The Great Room (Rm[removed]White Oak Conference Center, Silver Spring, Mar

Add to Reading List

Source URL: www.fda.gov

Language: English
5Microsoft Word - DRAFT Agenda AAC[removed]doc

Microsoft Word - DRAFT Agenda AAC[removed]doc

Add to Reading List

Source URL: www.fda.gov

Language: English
6Microsoft Word - DRAFT Questions AAC[removed]doc

Microsoft Word - DRAFT Questions AAC[removed]doc

Add to Reading List

Source URL: www.fda.gov

Language: English
7Disclosure Form: Christopher R. Snell

Disclosure Form: Christopher R. Snell

Add to Reading List

Source URL: www.fda.gov

Language: English
8JCI LIMITED (“the Company”) ANNOUNCEMENT TO SHAREHOLDERS 01 JULY 2014 UPDATE OF LEGAL MATTERS : HEMISPHERX BIOPHARMA INC.

JCI LIMITED (“the Company”) ANNOUNCEMENT TO SHAREHOLDERS 01 JULY 2014 UPDATE OF LEGAL MATTERS : HEMISPHERX BIOPHARMA INC.

Add to Reading List

Source URL: www.jci.co.za

- Date: 2014-07-01 07:49:22
    9Differential Exercise Responses to Rintatolimod Exhibited by Patients with Severe Chronic Fatigue Syndrome (CFS) David R. Strayer1, Bruce C. Stouch2, William A. Carter1, and William M. Mitchell3 1Hemispherx  Biopharma, I

    Differential Exercise Responses to Rintatolimod Exhibited by Patients with Severe Chronic Fatigue Syndrome (CFS) David R. Strayer1, Bruce C. Stouch2, William A. Carter1, and William M. Mitchell3 1Hemispherx Biopharma, I

    Add to Reading List

    Source URL: www.hemispherx.net

    Language: English - Date: 2014-03-24 07:22:18